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Abstract 
It has been described that the sensitivity of the Carba NP test may be low in the case of 
OXA-48-like carbapenamases and mass spectrometry based methods as well as a 
colorimetry based method have been described as alternatives. We evaluated 84 
Enterobacteriaceae isolates including 31 OXA-48-like producing isolates and 13 isolates 
that produced either an imipenemase (IMP; n=8), New Delhi metallo-β-lactamase 
(NDM; n=3), or Klebsiella pneumoniae carbapenemase (KPC; n=2), as well as 40 
carbapenemase negative Enterobacteriaceae isolates. We used the Neo-Rapid CARB 
kit, assessing the results with the unaided eye and compared it with a colorimetric 
approach. Furthermore, we incubated the isolates in growth media with meropenem and 
measured the remaining meropenem after one and two hours of incubation, 
respectively, using liquid chromatography tandem mass spectrometry (LC-MS/MS). 
Whilst all carbapenemase producing isolates with the exception of the OXA-244 
producer tested positive for both the Neo-rapid CARB test using the unaided eye or 
colorimetry, and the 13 isolates producing either IMP, NDM or KPC hydrolysed the 
meropenem in the media almost completely after two hours of incubation, the 31 OXA-
48-like producing isolates exhibited very variable hydrolytic activity when incubated in 
growth media with meropenem. In our study, the Neo-Rapid CARB test yielded a 
sensitivity of 98% for both the traditional and the colorimetric approach with a specificity 
of 95% and 100% respectively. Our results indicate that the Neo-Rapid CARB test may 
have use for the detection of OXA-48 type carbapenemases and that it may be 
particularly important to ensure bacterial lysis for the detection of these weaker 
hydrolysers. 
 
 
Keywords: OXA-48-like; Neo-rapid CARB test; LC-MS/MS; colorimetry; 
Enterobacteriaceae 
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1. Introduction 
In Enterobacteriaceae, carbapenemases are frequently encoded by genes located on 
mobile elements that may transfer between bacterial strains, species or even genera 
(Goodman et al., 2016). Phenotypic tests such as the modified Hodge test or the Carba 
NP test are used to evaluate the presence of carbapenemases (Lutgring and Limbago, 
2016).  
The Carba NP test was first published in 2012. It utilises an acid base indicator (phenol 
red) to detect the hydrolysis of imipenem by a carbapenemase (Dortet et al., 2015). 
Many commercial tests such as the Rapidec CARBA NP test (bioMérieux, Marcy-
l'Étoile, France), the Rapid CARB screen (Dortet et al., 2015) and its replacement the 
Neo-rapid CARB kit (Rosco Diagnostica, Taastrup, Denmark) are now available for the 
detection of carbapenemase activity (Casals, 2015). 
It has recently been suggested that the solutions of the Carba NP test may be prepared 
in advance and stored at -70°C for up to a year (Knox et al., 2016). However, the 
general agreement is that the test solution needs to be prepared when needed, making 
its preparation laborious (Gallagher et al., 2015). Furthermore, using imipenem for 
research purposes is not cost-effective, and it may only be economically viable if 
powder aliquots of pharmaceutical formulations are used. However, these formulations 
contain other ingredients such as cilastatin (a dehydropeptidase inhibitor blocking the 
renal metabolism of imipenem) and in case of the intravenous form sodium 
hydrogencarbonate which may interfere with the pH reaction. The intramuscular 
imipenem formulation lacking sodium hydrogencarbonate may be used instead, 
however this formulation is not available in all countries (AbdelGhani et al., 2015).  
In a personal communication with Merck Switzerland we were informed that from a 
manufacturing perspective all ingredients in the imipenem / cilastatin preparation 
Tienam could be evenly distributed, but since the use as a powder for in vitro testing is 
not the intended use, the even distribution has not been tested and it cannot be 
guaranteed.  
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For these reasons it might be preferable to use a commercial kit instead of an in-house 
preparation of the Carba NP test. 
There is variation in the literature on the reported accuracy of the Carba NP test to 
detect carbapenemase activity (Dortet, Agathine, Naas, Cuzon, Poirel and Nordmann, 
2015, Goodman, Simner, Tamma and Milstone, 2016, Hombach et al., 2015, Lutgring 
and Limbago, 2016, Papagiannitsis et al., 2015). OXA-48 like β-lactamases are weak 
hydrolysers of carbapenems conferring only low levels of resistance in some isolates. 
This may impede the detection of these carbapenemases, which may have significant 
implications for treatment and infection control (Poirel et al., 2012).  
Mass spectrometry based methods have previously been described for the detection of 
carbapenemases, using Liquid Chromatography-Tandem Mass Spectrometry (LC-
MS/MS) (Kulkarni et al., 2014, Peaper et al., 2013) and more commonly matrix-assisted 
laser desorption time of flight mass spectrometry (MALDI-TOF MS) (Hrabak et al., 2012, 
Lutgring and Limbago, 2016). Papagiannitsis and colleagues recently proposed that 
MALDI-TOF MS may be superior to the Carba NP test in the detection of OXA-48- type 
producers, and it has also been indicated that the use of an Elisa microplate reader may 
help improve the sensitivity of colour changes in order to detect OXA-48-like producers 
(Papagiannitsis, Studentova, Izdebski, Oikonomou, Pfeifer, Petinaki and Hrabak, 2015). 
Here we investigated 84 bacterial isolates, both carbapenemase positive and negative. 
Carbapenemase producing organisms included 31 OXA-48-like producing isolates and 
13 isolates that produced other carbapenemases. We were using the Neo-rapid CARB 
kit as per package insert and comparing it with a colorimetric approach using a 
microplate reader. We further evaluated the hydrolysis of meropenem by these isolates 
using LC-MS/MS. The two latter approaches did not require subculturing for disc testing 
and the duration of test could therefore be cut down by one day. 
 
2. Materials and Methods 
2. 1. Isolates included in the study:   
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Forty four carbapenemase producing and 40 carbapenemase negative 
Enterobaceriaceae of the following description were investigated:  
The carbapenemase producing isolates included 31 OXA-48-like producing isolates, 
eight imipenemase (IMP) producing isolates, three New Delhi β-lactamase (NDM) 
producing isolates and two Klebsiella pneumoniae carbapenemase (KPC) producing 
isolates (table 1). 
 
The OXA-48-like producing isolates were of the following Enterobacteriaceae species: 
Klebsiella pneumoniae (n=28), Escherichia coli (n=1), Klebsiella oxytoca (n=1) and 
Enterobacter cloacae (n=1). The IMP producing isolates consisted of four E. cloacae, 
two K. pneumoniae and two E. coli isolates, the NDM producing isolates consisted of 
two E. coli isolates and one K. pneumoniae isolate, and the two KPC producing isolates 
were E. coli. Resistance testing and carbapenemase screening had been performed as 
previously described for the carbapenemase positive isolates as well as two 
carbapenemase negative K. pneumoniae isolates (Kim et al., 2012, Sidjabat et al., 
2014, Sidjabat et al., 2015, Sidjabat et al., 2015, Wailan et al., 2015, Wailan et al., 2015, 
Zowawi et al., 2014). The geographic regions of origin of the carbapenemase positive 
isolates are indicated in table 1. 
 
Thirty eight Enterobacteriaceae isolates that were resistant to ertapenem by disc 
susceptibility testing as interpreted using EUCAST standard (EUCAST, 2013) were 
subsequently added to the study. These isolates had been tested negative for the 
production of carbapenemases using the modified Hodge test with ertapenem, 
imipenem and meropenem discs (Genc et al., 2016). These were provided by two local 
hospitals and included twenty two E. coli isolates, twelve K. pneumoniae isolates, three 
E. cloacae isolates and one Enterobacter aerogenes isolate.  
 
2. 2. Sequencing of blaOXA-48-like genes: 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
6 
 
 
The blaOXA-48-like genes were further investigated by amplification and sequencing with 
the primer set Pre_Oxa48Aplus (5’-CAGTATATTGCATTAAGCAAGGG-3’) and 
Pre_Oxa48B (5′- CACACAAATACGCGCTAACC -3′). These were based on primers 
previously described (Poirel et al., 2011).The following PCR conditions were applied: 
Initial denaturation, 95°C for five minutes followed by 35 cycles of denaturation at 95°C 
for 30 seconds, annealing at 50°C for 30 seconds and extension at 70°C for one minute. 
The final extension was done for 10 minutes at 72°C. Primer synthesis, PCR 
amplification and sequencing was performed by Macrogen, Seoul, Korea.  
 
The sequences were aligned with the DNA Baser (v.3.5.0) and the sequences were 
translated making use of the EMBOSS Transeq tool 
(http://www.ebi.ac.uk/Tools/st/emboss_transeq/), and blasted against the NCBI 
Genbank (http://blast.ncbi.nlm.nih.gov/Blast.cgi) for identification.  
 
2. 3. Detection of carbapenemases in live bacterial cells using LC-MS: 
Two McFarland of each bacterial isolate was incubated in 5ml of Mueller Hinton broth 
(Oxoid, Basingstoke, RG24 8PW, UK) with 4µg/ml meropenem at 37°C while shaking 
for one or two hours respectively. The meropenem was subsequently extracted using 
methanol with 1% formic acid, and purified using a Strata X 33µ Polymeric Reversed 
phase cartridge (Phenomenex, Torrance, CA 90501-1430 USA).  Samples were 
analysed using the QTRAP 5500 System (AB Sciex, Redwood City, CA, USA) and the 
MicroLC 200 System (Eksigent, Redwood City, CA, USA).  The 50 um electrode was 
used in the TurboV source to improve the sensitivity.   
 
The following mobile phases were used: The aqueous solvent A consisted of 5mM 
ammonium formate and the organic solvent B consisted of 99.9% acetonitrile with 0.1% 
formic acid. A HALO C18 (AB Sciex, Redwood City, CA, U.S.A) (2.7µm 90Å, 0.5 x 
50mm) column was used for the separation of compounds, and the following gradient 
was applied: Isocratic flow rate of 2% Solvent B for one minute, 2-20% B for 4 minutes, 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
7 
 
 
20-90% B for 30 seconds, isocratic flow at 90% B for 2.5 minutes, back to 2% B within 2 
minutes.  The Flow rate used was 25 uL/min.   
 
The collision energy (CE) and declustering potential (DP) were optimised making use of 
the Analyst software 1.6.2, and were 25 V and 96 V respectively for both meropenem and 
the internal standard [2H6]-meropenem, and the following MRM settings were obtained: 
m/z 384.1 → 141.0 for meropenem and m/z 390.165 → 146.9 for [2H6]-meropenem. 
 
Relative quantification was performed by peak integration making use of Analyst 1.6.2, 
and dividing the peak areas of 100ng/ml of [2H6]-meropenem by the peak area of the 
incubated meropenem with the respective strain for one and two hours. The relative 
peak areas were subsequently compared with the relative peak area of the E. coli 
ATCC 25922 negative control.  
 
2. 4. Neo-Rapid CARB kit using colorimetry: 
Isolates were incubated overnight on Mueller Hinton Agar (Becton Dickinson, Sparks, 
USA) and one full 10µl loop of each isolate was lysed using 150µl of the B-PERII 
Bacterial Protein Extraction Reagent (Thermo Scientific, Rockford, IL, USA). The 
suspension was vortexed for one minute and then kept at room temperature shaking for 
30minutes. Fifty microliters of each bacterial suspension was added to two tubes with 
100µl of saline, and a Neo-Rapid CARB Imipenem (x2) + Indicator Diatab (Rosco 
Diagnostica, Taastrup, Denmark) was added to one and a Negative Control Diatab was 
added to the other tube. The tubes containing the tablets were vortexed and incubated 
for 2 hours at 37°C shaking at 250rpm. After incubation, the tubes were centrifuged at 
17000 g for 5 minutes and 50µl of the supernatant was transferred to a NunclonTM delta 
surface 96 well plate (Thermo Scientific, Roskilde, Denmark). Absorbance was 
measured at 560 nanometres making use of a Spark 10M multimode microplate reader 
(Tecan Group Ltd. Maennedorf, Switzerland). 
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2. 5. Neo-Rapid CARB kit using the unaided eye: 
The test was performed as per insert, using Ertapenem Antimicrobial Susceptibility Test 
Discs, BBL™ Sensi-Disc™,10µg (Becton Dickinson, Sparks, USA). Stored isolates 
were cultured overnight using Mueller Hinton agar plates (Becton Dickinson, Sparks, 
USA) and the isolates were subcultured by lawning 0.5 McFarland onto new plates and 
an ertapenem disc was added. One full 10µl loop was suspended in 200µl B-PER II 
buffer diluted 1:1 with 0.9% NaCl and the suspension was vortexed for 1 minute and 
maintained at room temperature for 30 minutes. Fifty microliters of the suspension were 
added to two tubes with 150µl of 0.9% NaCl, and one Imipenem(x2) + Indicator (CARB) 
diatab was added to one tube and the CARB Negative Control Diatab was added to the 
other tube. The tubes were vortexed for 1-2s in order to disintegrate the tablet. The 
samples were incubated at 37°C and results were read by blinded lab personnel after 
15 minutes, 30 minutes, one and two hours respectively. 
 
 
 
3. Results  
 
3. 1. Sequencing of blaOXA-48-like genes: 
 
Full sequencing of the blaOXA-48-like genes revealed that twenty eight out of the thirty one 
isolates carried blaOXA-48, whereas one isolate each carried blaOXA-181, blaOXA-232 and 
blaOXA-244, respectively (table 1). 
 
3. 2. Detection of carbapenemases in live bacterial cells using LC-MS/MS: 
All the 40 carbapenemase negative isolates had their relative peak area reduced by a 
factor that ranged between 0.7 and 2.3 compared with the E. coli ATCC 25922 negative 
control.  
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The isolates that produced either NDM, IMP or KPC demonstrated strong hydrolytic 
activity. After one hour of incubation, one NDM positive K. pneumoniae isolate had 
meropenem reduced by a factor of six, and the other twelve isolates had the 
meropenem reduced by a factor of thirty or more. All thirteen isolates had meropenem 
decreased by a factor of above one hundred after two hours of incubation (table 1).  
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      Table 1 
Isolate Species 
Geographical 
Origin 
Name Carbapenemase 
Level of meropenem peak 
area reduction compared 
with E. coli ATCC 25922 
     1h incubation 2h incubation 
1 K. pneumoniae Arabian Peninsula 
Penninsula 
KPMC-10 KP NDM 5.9 >100 
2 E. coli Australia CR694 NDM-5 48 >100 
3 E. coli Australia CR53 NDM-4 30 >100 
4 E. coli USA YDC 419 KPC-2 71 >100 
5 E. coli USA YD 648 KPC-2 57 >100 
6 E. coli Australia Ec1 IMP-4 49 >100 
7 E. coli Australia CR48 IMP-4 >100 >100 
8 E. cloacae Australia CR19 IMP-4 >100 >100 
9 E. cloacae Australia CR17 IMP-4 >100 >100 
10 E. cloacae Australia CR12 IMP-4 >100 >100 
11 K. pneumoniae Australia CR9 IMP-4 92 >100 
12 E. cloacae Australia CR11 IMP-4 >100 >100 
13 K. pneumoniae Australia CR10 IMP-4 >100 >100 
14 K. oxytoca Arabian Peninsula 
Penninsula 
OMN-35 OXA-48 >100; >100 >100; >100 
15 E. cloacae Arabian Peninsula 
Penninsula 
OMN-48 OXA-48 >100; >100 >100; >100 
16 K. pneumoniae Arabian Peninsula 
Penninsula 
OMN-50 OXA-48 11; 7.6 >100; >100 
17 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-002 OXA-48 49; >100 >100; >100 
18 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-003 OXA-48 15; 21 >100; 27.8 
19 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-014 OXA-48 4.5; 5.3 >100; >100 
20 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-020 OXA-48 3.7; 2.7 >100; >100 
21 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-021 OXA-48 4.3; 3.1 >100; >100 
22 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-027 OXA-48 17; 5.4 >100; >100 
23 K. pneumoniae Arabian Peninsula 
Penninsula 
Egy-6 OXA-48 17; 5.0 46; >100 
24 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-070 OXA-48 9.0; 47 >100; >100 
25 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-039 OXA-48 3.2; 2.1 19; 7.5 
26 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-001 OXA-48 0.1; 0.6 1.5; 1.5 
27 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-005 OXA-48 0.9; 0.9 3.2; 3.7 
28 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-007 OXA-48 1.4; 0.7 2.7; 4.0 
29 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-008 OXA-48 1.0; 0.7 3.2; 2.7 
30 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-015 OXA-48 0.7; 0.5 1.3; 1.5 
31 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-018 OXA-48 0.8; 0.6 1.2; 1.1 
32 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-022 OXA-48 1.0; 0.5 1.1; 0.8 
33 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-023 OXA-48 1.2; 0.5 2.1; 1.3 
34 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-025 OXA-48 1.2; 0.4 1.9; 1.9 
35 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-028 OXA-48 2.5; 1.8 6.5; 5.0 
36 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-029 OXA-48 1.1; 1.3 2.6; 2.5 
37 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-031 OXA-48 1.4; 1.4 4.0; 5.5 
38 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-032 OXA-48 1.4; 1.3 2.9; 4.0 
39 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-034 OXA-48 1.3; 1.0 1.1; 1.2 
40 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-036 OXA-48 1.3; 1.1 1.8; 1.9 
41 K. pneumoniae Arabian Peninsula 
Penninsula 
SA-038 OXA-48 1.1; 1.4 1.6; 2.1 
42 K. pneumoniae Arabian Peninsula 
Penninsula 
QTR-46 OXA-181 0.2; 1.3 3.0; 2.5 
43 K. pneumoniae Arabian Peninsula 
Penninsula 
QTR-35 OXA-232 0.2; 1.0 2.4; 1.9 
44 E. coli Arabia  Peninsula QTR-23 OXA-244 0.2; 1.8 6.9; 14 
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Table 1: Results of meropenem reduction assay for n = 44 carbapenemase-producing 
Enterobacteriaceae clinical isolates. Isolates were cultured in Mueller Hinton broth 
containing 4µg/ml meropenem, and concentrations of meropenem were measured at 
one hour and two hour time points using liquid chromatography tandem mass 
spectrometry (LC-MS/MS). Reductions in meropenem concentrations in cultured 
isolates were calculated relative to that observed in an E. coli ATCC 25922 control. The 
experiments were repeated for the OXA-48-like carbapenemase producers and both 
results are listed in the table. The isolates 1 and 14 to 44 originated from the Arabian 
Peninsula (Zowawi, Sartor, Balkhy, Walsh, Al Johani, AlJindan, Alfaresi, Ibrahim, Al-
Jardani, Al-Abri, Al Salman, Dashti, Kutbi, Schlebusch, Sidjabat and Paterson, 2014), 
the isolates 2 (Wailan, Paterson, Kennedy, Ingram, Bursle and Sidjabat, 2015), 3 and 6-
13 (Sidjabat, Townell, Nimmo, George, Robson, Vohra, Davis, Heney and Paterson, 
2015) were of Australian origin and isolates 4 and 5 originated from the United States of 
America (Kim, Qureshi, Adams-Haduch, Park, Shutt and Doi, 2012).  
 
The 31 OXA-48-like producing isolates showed variable degradation of meropenem in 
the MHB media culture assay as measured by LC-MS/MS. This was also the case 
amongst the 28 isolates that were producing OXA-48 and not a variant. The 
experiments for these 31 Oxa-48-like producing isolates were repeated with results 
shown in table 1.  
 
The blaOXA-244 carrying E. coli isolate showed no detectable hydrolysis after 1h of 
incubation compared with the carbapenemase negative isolates. However, the amount 
of meropenem was reduced by a factor of seven and fourteen after two hours of 
incubation in two separate experiments.  
 
The amount of meropenem was not reduced compared with the E. coli  ATCC 25922 
negative control in the OXA-181 producing K. pneumoniae isolate after one hour of 
incubation. After two hours of incubation, meropenem was reduced by a factor of two or 
three respectively, showing very little hydrolysis. For the blaOXA-232 positive K. 
pneumoniae isolate, no reduction of meropenem could be detected after one or two 
hours of incubation compared with the carbapenemase negative isolates investigated in 
this study. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
12 
 
 
 
One blaOXA-48 positive K. oxytoca, one E. cloacae and one K. pneumoniae isolate each 
hydrolysed meropenem almost completely after one hour already.  
 
In the case of eight blaOXA-48 positive K. pneumoniae isolates, meropenem was reduced 
by a factor of three or more compared with the E. coli ATCC 25922 negative control 
after one hour of incubation. After two hours of incubation with these eight strains, 
meropenem was hydrolysed almost completely. 
  
The remaining twenty blaOXA-48 positive K. pneumoniae isolates showed little or no 
hydrolysis (table 1). 
 
3. 3. Neo-Rapid CARB kit using colorimetry: 
Using colorimetry, the Neo-Rapid CARB test yielded a sensitivity of 98% and a 
specificity of 100%. 
  
Whilst the absorbance at 560 nm was the same or higher for the imipenem containing 
test than the control for all carbapenemase negative isolates, the absorbance was lower 
for the imipenem containing test than the control for all but one carbapenemase positive 
isolate.  
 
When dividing the absorbance of the Neo-Rapid CARB negative control by the 
absorbance of the test containing imipenem, all 40 carbapenemase negative isolates 
had a relative absorbance of one or less.  
 
Forty three out of the 44 carbapenemase positive isolates (98%) had an absorbance 
which was lower in the sample with imipenem than the control and had therefore a 
relative absorbance above one. The exception was the OXA-244 positive isolate. One 
OXA-48 positive, one IMP positive and the OXA-232 positive K. pneumoniae isolate had 
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a relative absorbance that ranged between 1.1-1.5. All other isolates had a relative 
absorbance of 1.6 or higher (Figure 1). 
 
 
 
 
 
Figure 1: Absorbance ratio at 560 nm of the Neo Rapid CARB negative control versus 
the test containing imipenem for the 84 isolates investigated in this study (x-axis). The y 
axis indicates the number of strains with the respective absorbance ratios. All 
carbapenemase negative isolates had a relative absorbance of either 1.0 or less. The 
OXA-244 isolate had a relative absorbance of 0.6 and was therefore considered 
negative. The OXA-232 positive isolate had a relative absorbance of 1.1. All other 
isolates had a relative absorbance of 1.3 or more. 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
14 
 
 
3. 4. Neo-Rapid CARB kit using the unaided eye: 
Using the unaided eye and the Neo-Rapid CARB kit as per package insert, a sensitivity 
of 98% was obtained, with a specificity of 95%. The only carbapenemase producing 
isolate that gave false negative results was the OXA-244 producer included in the study. 
Two carbapenemase negative isolates were identified as positive, one of which was an 
E. coli isolate which was positive after 15 minutes and then turned uninterpretable due 
to colour change to yellow of the control. The other was a K. pneumoniae isolate which 
turned positive after two hours of incubation.  
 
4. Discussion 
We tested 84 Enterobacteriaceae isolates including 40 carbapenemase negative 
isolates, 31 OXA-48 like producers (OXA-48; n = 28, OXA-181; n = 1 and OXA-244; n = 
1), as well as 13 isolates producing either IMP (n = 8), NDM (n = 3) and KPC (n = 1) 
using the Neo-Rapid CARB test. We compared the Neo-Rapid CARB test using the 
unaided eye versus a colorimetric approach using a multiplate reader to interpret colour 
change. We also assessed the reduction in meropenem by incubation of the isolates in 
MHB growth media for one or two hours respectively, using a LC-MS/MS instrument for 
quantitation.   
We found a specificity 95% for the Neo-Rapid CARB test using the unaided eye and 
100% for the colorimetric approach. When incubating the 40 carbapenemase negative  
isolates in growth media with meropenem, the amount of remaining meropenem varied 
between 0.43 and 1.43 times the E. coli ATCC 25922 control after two hours of 
incubation. 
Previous studies suggested that the Carba NP test may have low sensitivity for OXA-
48-like producing isolates (Goodman, Simner, Tamma and Milstone, 2016, Lutgring and 
Limbago, 2016, Papagiannitsis, Studentova, Izdebski, Oikonomou, Pfeifer, Petinaki and 
Hrabak, 2015). However in our isolate collection we identified 30 out of the 31 OXA-48-
like producing isolates by both the Neo-Rapid CARB test interpreted using the unaided 
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eye as well as the colorimetric approach. The only exception was the OXA-244 
producing isolate, an OXA-48-type carbapenemase that had previously been described 
not to be reliably detected with the Carba NP test (Dortet, Agathine, Naas, Cuzon, 
Poirel and Nordmann, 2015, Dortet et al., 2016).  
Whilst the sensitivity was 98% for the Neo-Rapid CARB test using both the unaided eye 
and the colorimetric approach, a very variable hydrolytic activity was detected when 
incubating the isolates in growth media with meropenem. All 13 isolates that produced 
either NDM, IMP or KPC had a remaining amount of meropenem that was less than 1% 
after two hours of incubation compared with the remaining meropenem of the E. coli 
ATCC 25922 negative control. However, this was only the case for 11 out of the 31 
OXA-48-like producers, some of which showed no increased hydrolytic activity 
compared with the 40 carbapenemase negative isolates.  
The fact that there was no major issue with detecting OXA-type carbapenemases with 
the Carba NP test, where a lysis step is involved, may indicate that the differences in 
meropenem degradation in the presence of live bacterial cells is not due to variability in 
expression of the enzyme, but due to additional resistance mechanisms such as 
decreased permeability (Poirel, Potron and Nordmann, 2012). In Gram-negative 
organisms β-lactamases are located in the bacterial periplasm, and carbapenemases 
generally enter Gram-negative bacteria through porins (Papp-Wallace et al., 2011). 
Weaker carbapenemases such as the OXA-48 type may need additional resistance 
mechanisms such as porin loss in order to confer high levels of carbapenem resistance 
(Poirel, Potron and Nordmann, 2012). Therefore, it may be particularly important to 
ensure lysis for the detection of OXA-48-type carbapenemase activity. In our study we 
were adhering to the package insert of the Neo-rapid CARB tests which states that the 
bacterial samples need to be vortexed in lysis buffer for one minute and leave them at 
room temperature for an additional 30 minutes.  
It has been suggested that an increased bacterial inoculum may be needed for the 
Carba NP test, in order to appropriately detect IMP, NDM and OXA-48 producers 
(Gallagher, Roundtree, Lancaster, Rudin, Bard, Roberts, Marshall, Bonomo and 
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Sullivan, 2015, Hombach, von Gunten, Castelberg and Bloemberg, 2015). Here we 
used a full 10µl loop and both the colorimetry based Neo-Rapid CARB test and the 
traditional test using the unaided eye had high specificity and sensitivity. 
Whilst the OXA-244 producer included in our study was the only isolate that tested falsly 
negative, meropenem degradation was detected when incubating the isolate in growth 
media. It has been suggested that whilst OXA-244 has similar hydrolytic activity as 
OXA-48 for ertapenem and meropenem, it hydrolyses imipenem much less efficiently 
(Potron et al., 2016), and the Neo-Rapid carb test may therefore not be suitable to 
detect OXA-244.  
 
5. Conclusions 
The traditional and the colorimetric approach of the Neo-Rapid carb test showed high 
levels of sensitivity (98% in both cases) and specificity (95% for the traditional approach 
and 100% for the colorimetric approach). Using colorimetry, the test was performed 
without disc testing and consequently results would be achieved one day earlier.  
OXA-244 producers may not reliably be detected by the Neo-Rapid CARB test (Dortet, 
Agathine, Naas, Cuzon, Poirel and Nordmann, 2015, Dortet, Jousset, Sainte-Rose, 
Cuzon and Naas, 2016, Potron, Poirel, Dortet and Nordmann, 2016), and sequencing of 
the blaOXA-48-like genes may help detecting this carbapenemase. 
Our results using the LC-MS/MS indicate that bacterial lysis may be particularly 
important for isolates producing OXA-48-like carbapenemases, as these are relatively 
weak carbapenem hydrolysers and other resistance mechanisms such as porin loss are 
likely to play a role (Poirel, Potron and Nordmann, 2012). 
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Highlights 
 The Neo-Rapid Carb test may accurately detect OXA-48-like carbapenemases. 
 Lysis may be essential for the detection of weaker carbapenemases such as 
OXA-48. 
 Colorimetry may be used to help interpret Neo-Rapid Carb test results. 
